Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;66(2):128-131.
doi: 10.1097/MAT.0000000000000936.

LVAD Outflow Graft Role in Pump Thrombosis

Yaron D Barac  1 , Adam Nevo, Jacob N Schroder, Carmelo A Milano, Mani A Daneshmand
Affiliations
Review

LVAD Outflow Graft Role in Pump Thrombosis

Yaron D Barac et al. ASAIO J. 2020 Feb.

Abstract

Left ventricular assist devices are (LVAD) used for circulatory support in patients with end-stage heart failure. Hemolysis/pump dysfunction is a well-known complication of this therapy with various etiologic causes. A small proportion of these complications are caused by outflow graft obstructions; this complication has received little attention in the scientific literature. Herein, we provide a comprehensive overview of the role of the LVAD outflow graft obstruction and its treatment options.

PubMed Disclaimer

References

    1. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol 2014.171: 368–376.
    1. Danielsen R, Thorgeirsson G, Einarsson H, et al. Prevalence of heart failure in the elderly and future projections: The AGES-Reykjavík study. Scand Cardiovasc J 2017.51: 183–189.
    1. Ponikowski P, Voors AA, Anker SD, et al.; ESC Scientific Document Group: 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016.37: 2129–2200.
    1. Miller LW, Pagani FD, Russell SD, et al.; HeartMate II Clinical Investigators: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007.357: 885–896.
    1. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS annual report: The evolution of destination therapy in the United States. J Heart Lung Transplant 2011.30: 115–123.